Lv6
1759 积分 2023-03-30 加入
The Evolving Landscape of Antibody-Based Cancer Therapies: From Monospecific to Multi-Specific and Beyond
3天前
已完结
Molecular imaging supports the development of multispecific cancer antibodies
3天前
已完结
The evolving landscape of bispecific antibodies in the treatment of lung cancer
3天前
已完结
Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
3天前
已完结
Interleukin 2-Based Cancer Immunotherapies: The Discovery of Next-Generation Antibody-Cytokine Bispecific Antibody Drug
5天前
已完结
Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy
9天前
已完结
A Review on Anticancer Potential and Structure-Activity Relationships (SAR) of Novel EGFR/HER2 Inhibitors
18天前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
1个月前
已完结
Targeted therapy in biliary tract cancer
1个月前
已关闭
Small-Molecule Modulators Targeting Coactivator-Associated Arginine Methyltransferase 1 (CARM1) as Therapeutic Agents for Cancer Treatment: Current Medicinal Chemistry Insights and Emerging Opportunities
1个月前
已完结
皖公网安备34019202002308
